Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-09 · accession 0001209191-22-061328 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-14 | 2022-12-09+ | KYNB | Graham Juan | CFO | S - Sale | $14.64 | -2,188 | 55.1K | -4% | -$32.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | S | D | 1,407 | $14.50 | 53,703 | D | — | — | (F2) Shares sold pursuant to a 10b5-1 plan. |
| 2 | Common | Common Stock | 2022-12-09 | S | D | 781 | $14.90 | 55,110 | D | — | — | (F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. |